Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - pärmseente ekstrakt+haimaksaõli - rektaalsuposiit - 23mg+69mg 48tk; 23mg+69mg 12tk; 23mg+69mg 6tk; 23mg+69mg 24tk

Eesti - eesti - Ravimiamet

first pharma oÜ - pärmseente ekstrakt+haimaksaõli - rektaalsuposiit - 23mg+69mg 6tk; 23mg+69mg 48tk; 23mg+69mg 12tk; 23mg+69mg 24tk

Eesti - eesti - Ecolab

ecolab deutschland gmbh -

Eesti - eesti - Ravimiamet

csl behring gmbh - süstevesi - süsteravimi lahusti - 2ml 1tk; 4ml 1tk; 40ml 1tk; 6ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

gedeon richter plc. - follitropiin alfa - anovulatsioon - suguhormoonid ja genitaalsüsteemi, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. kliinilistes uuringutes on nendel patsientidel olid määratletud on endogeensed seerumi lh tase < 1. 2 rÜ / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.